Mindray Bio-Medical Electronics

Explore the latest insights on Mindray Bio-Medical Electronics and its impact on China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of Mindray Bio-Medical Electronics’ developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Explore the latest insights on Mindray Bio-Medical Electronics and its impact on China's pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of Mindray Bio-Medical Electronics' developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Brii Biosciences Launches BRiSC Bispecific siRNA Platform – Dual‑Target RNAi Engine to Advance Next‑Generation RNA Therapeutics in Prevalent Diseases
CompanyR&D

Brii Biosciences Launches BRiSC Bispecific siRNA Platform – Dual‑Target RNAi Engine to Advance Next‑Generation RNA Therapeutics in Prevalent Diseases

Brii Biosciences Limited (HKG: 2137) announced the launch of its proprietary BRiSC (Bispecific RNAi iSilenCing) small interfering RNA (siRNA) drug discovery platform, designed to advance the development of next‑generation ribonucleic…

AbbVie's RINVOQ Wins NMPA Approval for Severe Alopecia Areata – Ninth Indication in China Three Months After EU Clearance

AbbVie’s RINVOQ Wins NMPA Approval for Severe Alopecia Areata – Ninth Indication in China Three Months After EU Clearance

CSPC Pharmaceutical's Trispecific Antibody SYS6088 Wins NMPA Clinical Trial Approval – PD‑1/VEGFA/CTLA‑4 Candidate Targets Advanced and Metastatic Solid Tumors

CSPC Pharmaceutical’s Trispecific Antibody SYS6088 Wins NMPA Clinical Trial Approval – PD‑1/VEGFA/CTLA‑4 Candidate Targets Advanced and Metastatic Solid Tumors

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDeals

Mindray Bio-Medical Re-Files for Hong Kong Listing After Initial Application Expiration

Mindray Reports Mixed Q1 2026 Results with Strong International Growth Offset by Domestic Weakness
Company

Mindray Reports Mixed Q1 2026 Results with Strong International Growth Offset by Domestic Weakness

Policy / Regulatory

NHSA Launches 6th VBP Tender for Medical Consumables in China, Targeting Drug-Coated Balloons

Shenzhen Mindray Eyes $1 B+ Hong Kong IPO With Huatai, JPMorgan On Board
CompanyDeals

Shenzhen Mindray Eyes $1 B+ Hong Kong IPO With Huatai, JPMorgan On Board

Mindray Bio-Medical Expands North American Warehouse to Enhance Operational Efficiency
CompanyMedical Device

Mindray Bio-Medical Expands North American Warehouse to Enhance Operational Efficiency

NMPA Approves Shenzhen Mindray's Innovative Dual-Mode Ultrasound Diagnostic System
CompanyMedical Device

NMPA Approves Shenzhen Mindray’s Innovative Dual-Mode Ultrasound Diagnostic System

CompanyDeals

Mindray Bio-Medical Partners with Nanjing Drum Tower Hospital to Boost Clinical Research

CompanyDeals

Caprico Biotechnologies and Mindray Medical Form Comprehensive Flow Testing Partnership

Show More